Fig. 2.
The PI3K/Akt survival pathway is a critical downstream target of the rat sarcoma virus (Ras) family of proteins, largely involved in cell proliferation. De-regulation of the PI3K/Akt signaling pathway is thought to affect at least 50% of all cancer patients and 60% of all PDAC patients (Murthy et al. 2018)